Using two GLP-1 medications simultaneously would increase the risk of serious side effects without additional benefit
The two mechanisms are placed side by side because they converge on the same protein, not because they are alternatives to one another
Or would the benefits be more subtle
Use: In combination with a reduced calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in patients with obesity Renal Dose Adjustments Renal dysfunction: Ozempic (injection and tablets) and Rybelsus tablets: No adjustment recommended Wegovy (injection and tablets): Data not available Liver Dose Adjustments Liver dysfunction: Ozempic (injection and tablets) and Rybelsus tablets: No adjustment recommended Wegovy (injection and tablets): Data not available Dose Adjustments ADULT PATIENTS: Switching Between Ozempic and Rybelsus Tablets: Do not switch between Ozempic and Rybelsus tablets during the initiation phase (days 1 to 30)

Victoza contains liraglutide and should not be coadministered with other liraglutide-containing products Indications and Limitations of Use Victoza (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease
Ozempic: $1,027.51 Wegovy (injectable): $349 Wegovy (pill): $199 Rybelsus: $997.58 Ro Body review: Could they be your weight loss journey partner